Research and Development

Kantar Health Names Werner Guminski CEO, Commercial StrategyNEW YORK, July 8, 2011—Kantar Health, a leading healthcare-focused global consultancy and marketing …

German healthcare spending cuts have gone too far and risk jeopardising pharmaceutical innovation in the country, according to Lilly’s chief …

Most senior managers find their executive team difficult. ‘Dysfunctional’ is a favourite word. Testing dynamics, political agendas, big personalities, strong …

Bristol-Myers Squibb has signed a $465 million deal for the rights to a potential first-in-class treatment for cancer. IPH2102 is …

Genticel has named Dr Didier Hoch, former president of Sanofi-Pasteur MSD, to its supervisory board as conseil de surveillance.Dr Hoch …

Sanofi has signed a research collaboration with Rib-X Pharmaceuticals to investigate new types of antibiotics. The French pharma company has …

Quintiles helps fund Alzheimer’s drug programme, Toxikon starts building a new facility, plus updates from Jubilant, CIToxLAB and PupPharma. Quintiles …

Pfizer has been drawn into a war of words over its smoking cessation drug Champix after a review of existing …

Merck & Co continues to shake up its network of facilities, deciding to close a recently-acquired site in the USA …

Novartis’ Afinitor has impressed in a late-stage trial by increasing survival in women with advanced breast cancer. The phase III …

Sterile filling specialist SCM Pharma has bolstered its senior management team with the appointment of Adams Sims as a non-executive …

Pharma companies have been given the highly-specific electronic formats in which they will soon have to submit information on medicines …

Eli Lilly has highlighted diabetes, oncology, autoimmune diseases and neuroscience as key therapy areas within its growth strategy. Within these …

Spanish pharma company Almirall has promoted Farid Taha to be its general manager for Germany. He joined Almirall in 2000 …

AstraZeneca has signed a deal with PTC Therapeutics to use the company’s proprietary drug discovery platform to discover new cancer …